Cardiac safety results from a phase II, open-label, multicenter, pilot study of two docetaxel-based regimens plus bevacizumab for the adjuvant treatment of subjects with node-positive or high-risk node-negative breast cancer
Hurvitz, Sara A, Bosserman, Linda D, Chan, David, Hagenstad, Christopher T, Kass, Frederick C, Smith, Frederick P, Rodriguez, Gladys I, Childs, Barrett H, Slamon, Dennis J
Published in SpringerPlus (12.05.2014)
Published in SpringerPlus (12.05.2014)
Get full text
Journal Article
Updated Results on the Clinical Activity of Entospletinib (GS-9973), a Selective Syk Inhibitor, in Patients with CLL Previously Treated with an Inhibitor of the B-Cell Receptor Signaling Pathway
Sharman, Jeffrey P., Shustov, Andrei R., Smith, Mitchell R., Hagenstad, Christopher T., Kolibaba, Kathryn S., Abella-Dominicis, Esteban, Zhang, Danjie, Mitra, Siddhartha, Yasenchak, Christopher A., Awan, Farrukh T.
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article